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Oxidative stress is reduced by the long-term use of vitamin trappers. Oxidative stress results when the balance be-
E-coated dialysis filters. tween oxidant production and antioxidant activity shifts
Background. Oxidative stress during hemodialysis is thought in favor of the former [2, 3].to promote the progression of vascular complications in hemo-
Clinical studies have confirmed that hemodialysisdialysis patients. The protective role of vitamin E as a lipophilic
(HD) is associated with the development of oxidativeantioxidant against oxidative stress has been widely investi-
gated. Here we investigated the effects of a vitamin E-coated stress and disturbance in the enzyme systems that protect
regenerated cellulose hollow fiber dialyzer (CL-EE) on oxida- against oxygen free radicals [4, 5]. The antioxidative re-
tive stress compared with a polysulfone hollow fiber (CL-PS). serve of uremic patients is significantly lower than inMethods. For at least three months before beginning the
normal subjects [6]. Moreover, HD is associated withprotocol, 10 nondiabetic (NDM) patients (70.0 6 7.5 years; 6
the activation of polymorphonuclear leukocytes, whichmales and 4 females) and 8 diabetic (DM) patients (65.0 6 7.4
years; 4 males, 4 females) were dialyzed with CL-PS. After are a major source of oxidants in vivo. When activated,
that, we treated all of the patients with CL-EE for six months. these cells exhibit a burst of oxygen consumption and
Malondialdehyde (MDA), advanced glycation end products
produce a variety of reactive substances, including super-(AGEs), and 8-hydroxydeoxyguanosine (8-OHdG) were moni-
oxide radicals, hydrogen peroxide, and hypochloroustored as biomarkers for oxidative stress at the start and then
at one, three, and six months into treatment with CL-EE. acid [7]. Accelerated oxidative stress is a pathogenic
Results. Serum MDA, AGE, and 8-OHdG levels increased factor in some common HD-related side effects such as
after the hemodialysis with CL-PS. The increase of the bio- anemia, defective immunologic and coagulative func-
markers was completely prevented by a single use of CL-EE.
tions, accelerated atherosclerosis and aging, b2-micro-Long-term hemodialysis with CL-EE for six months signifi-
globulin (b2m) amyloid arthropathy, and carcinogenesiscantly reduced the basal levels of the oxidant markers at one
month for AGE and at six months for 8-OHdG in both DM [8]. While synthetic membranes have significantly im-
and NDM patients. Serum MDA was reduced in only DM proved biocompatibility, the problem of oxygen-free
patients at three months. The improvement of the oxidative radical production during HD remains largely unre-stress with CL-EE was more prominent in the DM patients.
solved [9], probably because of the insufficient level ofConclusions. Long-term treatment with CL-EE efficiently
biocompatibility achieved and the multiple mechanismsimproves the oxidative stress associated with hemodialysis and
potentially reduces dialysis complications due to oxidative stress. involved in oxygen free radical production [8].
Because vitamin E acts as a powerful hydrophilic scav-
enger to protect plasma lipids and cell membranes from
The generation of oxygen-free radicals is a major peroxidative events [10], the use of HD filters with vita-
pathogenic factor for tissue damage in many clinical con- min E-coated surface was proposed as a novel approach
ditions [1]. Levels of oxygen-free radicals are normally to reduce the accelerated generation of reactive oxygen
kept in check by an array of biochemical defense mecha- species. Previous studies have suggested that a vitamin
nisms, which include enzyme scavengers and antioxidant E-coated membrane is a highly biocompatible material,
the antioxidant properties of which can exert a site-spe-
cific and timely scavenging function against oxygen-freeKey words: advanced glycation end-products, malondialdehyde,
8-hydroxydeoxyguanosine, diabetes mellutus, antioxidant. radicals in synergy with a hypostimulatory action on the
polymorphonuclear respiratory burst [11–14].Received for publication June 30, 2000
The present study was designed to elucidate the poten-and in revised form October 30, 2000
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Table 1. Clinical features of the study groups After six months of using the CL-EE filter, the dialyzer
was exchanged for CL-PS again.Non-diabetic Diabetic
Group patients patients
Blood samplingN (male/female) 10 (6/4) 8 (4/4)
Age years 70.567.5 65.067.4 Blood was withdrawn at the time of routine laboratory
Dry wt kg 52.565.5 48.265.8
investigations on the first treatment day of the first weekHbA1c % ND 6.460.7
Duration of dialysis months 58.467.2 57.3614.1 of every month. Blood was collected from the arterial line
Mean effective blood flow mL/min 204.0618.4 197.5612.8 just before HD treatment on four occasions per patient:
Data are mean 6 SD. Abbreviations are: HbA1c, hemoglobin A1c; ND, not before (0 month) and after one, three, or six months of
done. All patients were treated with standard bicarbonate HD at a flow rate of
using CL-EE membrane. Furthermore, blood was taken500 mL/min from a central supply system. They were dialyzed three times weekly
for 4 hours and stabilized in a condition of good clinical metabolic equilibrium. at three months after changing the dialyzer back to the
Dialyzers were not reused.
CL-PS membrane (9 months). Before using the CL-EE
membrane (0 month) and at the first HD with the CL-EE
membrane, a blood sample was withdrawn from the arte-
rial line before and after HD treatment for evaluationby measuring the levels of malondialdehyde (MDA),
advanced glycation end products (AGE), and 8-hydroxy- of the elimination rate. Blood samples were immediately
mixed with butylated hydroxytoluene to prevent furtherdeoxyguanosine (8-OHdG) as indicators. We also eluci-
dated the long-term effects of this new generation of bio- oxidation and with potassium-ethylenediaminetetraacetic
acid (K-EDTA). Blood samples were centrifuged, sepa-materials on the correction of oxidative damage in HD.
Our results confirmed that oxidant stress could be pre- rated into cryotubes, and stored frozen at 2808C within
60 minutes of collection until assay. Each assay was car-vented, or at least reduced, by using a vitamin E-coated
membrane. ried out on duplicate samples.
Assays
METHODS
Serum AGE concentrations were measured by a newly
Patients developed enzyme-linked immunosorbent assay (ELISA)
method using anti-AGE keyhole limpet hemocyanin,Ten nondiabetic (NDM) patients, aged from 59 to 77
years (70.0 6 7.5 years; mean 6 SD, 6 males and 4 fe- which mainly recognizes carboxymethyllysine (CML).
The concentrations of MDA were evaluated from themales), and 8 diabetic (DM) patients, aged from 52 to
72 years (65.0 6 7.4 years; 4 males and 4 females) under- reaction resulting in the formation of thiobarbituric acid
reactive substances according to method of Yagi [15].going maintenance HD for more than three years were
enrolled in this study (Table 1). Patients with any of Briefly, lipids and proteins were precipitated using 10%
phosphotungistic acid and N/12 sulfuric acid. The sedi-the following conditions were excluded from the study:
smokers, if they were taking antioxidants, had acute or ment was resuspended in distilled water followed by the
addition of thiobarbituric acid. The reaction mixture waschronic infections, evidence of malignancy, or those with
considerable iron overload or rheumatological disorders. heated at 958C for 60 minutes; thiobarbituric acid (TBA)-
reacting substances were extracted with butanol. AfterThe duration of dialysis was from 50 to 67 months (58.4 6
7.2 months) in NDM patients and from 37 to 78 months centrifugation, the butanol layer was taken for fluoro-
metric measurement at 515 nm excitation and 550 nm(57.3 6 14.1 months) in DM patients. Blood glucose in
all DM patients was controlled by a subcutaneous insulin emission. The concentration of 8-OHdG was determined
using commercially available competitive ELISA kitsinjection. Dialyzers were not reused. We used bicarbon-
ate dialysate at a flow of 500 mL/min from a central (8-OHdG Check; Japan Institute for Control of Aging,
Fukuroi, Shizuoka, Japan). The kit can measure 8-OHdGsupply system. Endotoxin levels in the dialysate had been
below the detection limit (,1.0 pg/mL) during the obser- values ranging from 0.64 to 2000 ng/mL. The specificity of
the monoclonal antibody N45.1 used in the competitivevation period. All patients were dialyzed three times
weekly for four hours and stabilized in a condition of ELISA kit has previously been established [16]. Mea-
surement of serum b2m was carried out by radioimmuno-good clinical metabolic equilibrium. Informed consent
was obtained from all patients. At the time of sample assay, an enzymatic method. Routine clinical parameters
(total protein, albumin, total cholesterol, hemoglobin,collection, no patients had any complications. For at least
three months before beginning the protocol, all patients and hemoglobin A1c) were determined by automatic
analyzer at the clinical laboratory, Hiroshima Prefectualwere dialyzed with a polysulfone 1.2 to 1.5 m2 hollow
fiber dialyzer, Cliranst PS (CL-PS; Terumo Corp., Welfare Federation of Agricultural Cooperative, Fuchu
General Hospital. Dialysis dose was calculated as double-Tokyo, Japan). HD, using a vitamin E-coated regener-
ated cellulose 1.2 to 1.5 m2 hollow fiber dialyzer, Cliranst pool Kt/V according to Daugirdas and Ing [17]. The
percentage of reduction in the serum concentration ofEE-N (CL-EE; Terumo Corp.) was then commenced.
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Table 2. Routine clinical parameters measured during the study
1 month 3 months 6 months
0 month 9 months
Filter type CL-PS CL-EE CL-PS
Total protein g/dL
NDM 6.5460.21 6.5860.20 6.6660.29 6.6260.20 6.5860.34
DM 6.3860.26 6.3360.55 6.4360.42 6.4460.56 6.3860.19
Albumin g/dL
NDM 3.9060.28 3.8660.22 3.9260.18 3.9160.29 3.8460.30
DM 3.7560.05 3.6960.19 3.8060.13 3.8360.21a 3.6860.25
Total cholesterol mg/dL
NDM 149636 156635 168630a 164646a 155640
DM 157629 162625 157635 172638a 156622
Hemoglobin g/dL
NDM 10.460.9 10.460.6 10.460.3 10.260.4 10.260.8
DM 10.461.1 10.060.8 10.060.9 10.060.6 10.261.4
EPO U/kg/week
NDM 75.9643.3 76.0643.3 70.1643.1 71.4631.3 84.2613.8
DM 104.4661.3 94.8675.3 93.6670.9 111.7666.3 103.5677.1
Kt/V
NDM 1.3060.11 1.3560.14 1.3260.15 1.3360.16 1.3360.16
DM 1.3560.15 1.3360.17 1.4160.24 1.3160.19 1.3260.18
Data are mean 6 SD. Abbreviations are: CL-PS, polysulfone dialyzer; CL-EE, vitamin E-coated regenerated cellulose dialyzer; EPO, erythropoietin; NDM, non-
diabetic patient group; DM, diabetic patient group.
a P , 0.05 vs. 0 month
each parameter was calculated as follows: [(serum con- Predialysis and postdialysis serum concentrations of
centration predialysis 2 serum concentration postdial- MDA using CL-PS or CL-EE membranes are shown in
ysis)/predialysis] 3 100 (%). Table 3. Before HD, serum MDA concentrations were
lower in the NDM group compared with the DM group
Statistical analysis (P , 0.01) with both CL-PS and CL-EE membranes.
Data are expressed as mean 6 SD. Differences be- HD with CL-PS membranes were associated with a sig-
tween groups were examined for statistical significance nificant rise in serum MDA levels in the DM group (P ,
using the Mann–Whitney Rank Sum test. A P value of 0.05 vs. predialysis). In the NDM group, serum MDA
less than 0.05 was denoted the presence of a statistically levels did not change during a single HD with CL-PS.
significant difference. In contrast, after a single HD session with CL-EE, serum
MDA levels significantly decreased compared with pre-
dialysis in both the NDM (P , 0.01) and DM groupsRESULTS
(P , 0.05). The reduction rates were significantly higherTable 2 shows various clinical parameters of patients
during HD with CL-EE membranes compared with HDparticipating in the study. There was no change in serum
with CL-PS membranes in both groups (P , 0.05). Figuretotal protein level between before (0 month) and after
1 shows changes in serum MDA levels during the courseuse of the CL-EE membrane for six months in either
of dialysis treatment with CL-EE membranes. Beforegroup. Serum albumin was significantly elevated in the
using CL-EE membranes, serum MDA levels wereDM group after using the CL-EE membrane for six
higher in the DM group than in the NDM group (P ,months (P , 0.05). In the NDM group, the total choles-
0.01). One month of treatment with the CL-EE mem-terol level was significantly higher after three months of
brane did not change MDA levels in both groups. Aftertreatment with the CL-EE membrane than the baseline
three months of treatment with CL-EE, the MDA con-level (P , 0.05). Similarly, in the DM group, total choles-
centration decreased significantly in patients of the DMterol level was significantly higher after six months of
group (P , 0.01 vs. 0 month); however, NDM patientstreatment with the CL-EE membrane than the baseline
did not show any significant reduction even after sixlevel (P , 0.05). After changing the membrane back
months. Serum MDA concentrations tended to increaseto CL-PS, albumin levels in the DM group and total
marginally in the DM group after changing back to thecholesterol levels in both groups returned to the baseline
CL-PS membrane.levels. During six months of treatment with the CL-EE
Advanced glycation end product concentrations, bothmembrane, hemoglobin levels and doses of erythropoie-
predialysis and postdialysis, were significantly lower intin required to maintain the hemoglobin level remained
the NDM group compared with the DM group (Tablestable. Kt/V, a parameter reflecting the effect of HD,
did not change during the observation periods. 3). Serum AGE levels were significantly higher after
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Table 3. Reduction rates of various parameters during a single hemodialysis session
CL-PS CL-EE
Predialysis Postdialysis RR % Predialysis Postdialysis RR %
MDA nmol/mL
NDM 3.0060.31b 3.0260.28b 21.168.4 2.9660.60b 2.8360.59d 9.864.3e
DM 3.6260.27 4.1060.37c 212.9613.9 3.5860.24 3.2960.19c 5.067.4e
AGE IU/mL
NDM 24.864.6b 30.565.2b,d 224.1612.6 25.862.2b 25.765.0a 2.3616.0f
DM 38.068.9 45.9612.4d 220.0610.5 39.269.3 39.1612.4 0.6631.8e
8-OHdG ng/mL
NDM 102.8678.9 135.8699.5d 232.6629.5 116.7694.3 122.9694.4 25.3616.2e
DM 230.46193.3 264.16253.1 215.1627.9 226.46143.8 215.96224.5 4.6612.7f
b2m mg/mL
DM 26.867.1 11.063.4d 59.763.3a 27.067.2 25.667.04 5.466.6f
DM 28.363.9 12.662.2d 55.463.1 28.266.4 26.766.9c 5.665.7f
Data are mean 6 SD. Abbreviations are: reduction rate (RR) was calculated as described in the Methods section. CL-PS, polysulfone dialyzer; CL-EE, vitamin
E-coated regenerated cellulose dialyzer; MDA, malondialdehyde; AGE, advanced glycation end products; 8-OHdG, 8-hydroxy-deoxyguanosine; b2m, b2-microglobulin;
NDM, non-diabetic patient group; DM, diabetic patient group.
aP , 0.05, bP , 0.01 vs. DM
cP , 0.05, dP , 0.01 vs. predialysis
eP , 0.05, fP , 0.01 vs. CL-PS
Fig. 2. Serum levels of advanced glycation end products (AGEs).Fig. 1. Serum levels of malondialdehyde (MDA). Changes in serum
Changes in serum AGE levels during the course of dialysis treatmentMDA levels during the course of dialysis treatment with a vitamin
with CL-EE membrane are shown. Serum AGE levels were significantlyE-coated regenerated cellulose hollow fiber dialyzer (CL-EE) mem-
higher in the DM group (j) than in the NDM group (h) at all observa-brane. At baseline, serum MDA levels were higher in the diabetic (DM;
tion points. After one month of treatment with CL-EE, a significantj) group than in the non-diabetic (NDM; h) group. After three months
reduction in the AGE concentration was noted in both groups. Afterof treatment with CL-EE, the MDA concentration significantly de-
three months of CL-EE use, there was a greater decrease in AGE increased in patients of the DM group. However, the NDM patients did
the DM group than the NDM group. After reverting to CL-PS, serumnot show any significant reduction even after six months. After reverting
AGEs in the NDM group returned to baseline levels. Data are mean 6to CL-PS, serum MDA increased to original levels in the DM group.
SD. #P , 0.01 vs. NDM group; *P , 0.05 and **P , 0.01, respectively,Data are mean 6 SD. #P , 0.01 vs. NDM group; *P , 0.01 vs. baseline
vs. baseline levels.level.
dialysis with the CL-PS membrane in both groups (P , the NDM and DM groups (P , 0.05 vs. 0 month, P ,
0.01 vs. 0 month). After reverting to the CL-PS mem-0.01 vs. predialysis), whereas no difference in these levels
was observed using the CL-EE membrane in either brane, serum AGE concentrations in the NDM group
returned to original levels, whereas serum AGE concen-group. The percentage of reduction in AGE concentra-
tion with CL-EE membrane was higher compared with trations in the DM group tended to increase but not to
the original pre-CL-EE membrane dialysis level.CL-PS membrane (P , 0.01, NDM group; P , 0.05,
DM group). Serum AGE levels were significantly higher Reduction rates in 8-OHdG concentrations during a
single HD session are shown in Table 3. During CL-PSin the DM group than in the NDM group at all of the
time intervals (P , 0.01; Fig. 2). A significant progressive membrane use, 8-OHdG increased during a single HD
session. In contrast, no significant increase of 8-OHdGdecrease in AGE concentrations was observed in both
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cell damage. Consistent observations have provided evi-
dence for the presence of oxidative stress in chronic renal
failure patients, particularly in HD. HD is accompanied
by activation of polymorphonuclear leukocytes, which
are the major source of oxidants in vivo. When activated,
these cells exhibit a burst of oxygen consumption and
produce a variety of reactive substances, including super-
oxide radicals, hydrogen peroxide, and hypochlorous
acid [7]. Use of a bioincompatible dialysis system results
in a dramatic increase in the production of reactive oxy-
gen species, thus reducing antioxidant defense mecha-
nisms. In recent years, the biocompatibility of synthetic
membranes has been markedly improved. However, the
problem of an oxidative stress resulting from HD re-
mains largely unresolved [9]. Previous studies suggestedFig. 3. Serum levels of 8-hydroxy-deoxyguanosine (8-OHdG). Changes
in serum 8-OHdG levels during the course of dialysis treatment with that vitamin E-modified filters could be effective in pro-
CL-EE membrane are shown. A significant reduction was noted in the tecting HD patients against damage caused by oxygen-
DM group (j) by three months of treatment with CL-EE. Serum
free radicals by decreasing the activation of polymorpho-8-OHdG levels also significantly decreased in the NDM group (h) after
six months of treatment. After reverting to CL-PS membrane, serum nuclear leukocytes and providing a better control of
8-OHdG tended to increase in both groups. Data are mean 6 SD. *P , blood lipoperoxidation and antioxidant status [11]. In
0.05 vs. baseline levels.
this study, we evaluated the long-term effects of a new
generation of biomaterials on the correction of oxidative
damage to lipids, proteins, and nucleic acids during HD.
Endotoxin in dialysate is one possible source of reac-was observed during CL-EE membrane use. The percent-
tive oxygen species in HD patients. Cytokine release byage of reduction in 8-OHdG concentration with CL-EE
neutrophils is enhanced by endotoxin [18], which pro-membrane was significantly higher than with CL-PS
duces a variety of reactive substances, including superox-membrane (P , 0.05, NDM group; P , 0.01, DM group).
ide radicals, hydrogen peroxide, and hypochlorous acid.Figure 3 shows changes in serum 8-OHdG levels during
We have used endotoxin cut filters to provide clean dialy-the course of dialysis with CL-EE membranes. In the
sate, such that endotoxin levels in dialysate were con-DM group, serum 8-OHdG levels were significantly re-
trolled to maximum detection sensitivity. Endotoxin wasduced by three months of treatment with CL-EE (P ,
considered to have no effect on HD patients by dialysate0.05 vs. 0 month). After 6 months of treatment, serum
back filtration.8-OHdG levels in the NDM group were also significantly
Serum albumin was significantly elevated in the DMdecreased (P , 0.05 vs. 0 month). Serum 8-OHdG levels
group after using the CL-EE membrane at six months.tended to increase in both groups after reverting to CL-
After changing the membrane back to CL-PS, albuminPS membrane.
levels in the DM group returned to the baseline levelsThe percentage of reduction in b2m concentrations
(see Table 2). In general, there is much more amountduring a single HD session is shown in Table 3. The
of albumin leak in polysulfone membrane compared withreduction rate in NDM patients using the CL-PS mem-
cellulose membrane. We considered that the albuminbrane was higher than in DM patients (P , 0.05). Reduc-
leak was improved yet a little by changed to the CL-EEtion rates were significantly lower in patients using the
membrane that is modified from cellulose based low-CL-EE membrane than the CL-PS membrane in both
flux membrane. The total cholesterol level in the bothgroups (P , 0.01). After several months of CL-EE mem-
groups significantly increased after treatment with thebrane use, serum b2m significantly and progressively in-
CL-EE membrane than the baseline level (see Tablecreased, compared with the values measured before CL-
2). A previous study has reported that there was noEE membrane use in both the NDM and DM groups
difference between high- and low-flux dialysis for the(data not shown). After changing back to the CL-PS
total cholesterol [19]. It is not unclear why total choles-membrane, serum b2m concentrations returned to the
terol levels increase, but it might be related to the declinelevels noted prior to CL-EE membrane use.
of the albumin level.
During the observation periods using CL-EE mem-
DISCUSSION branes, hemoglobin levels and doses of erythropoietin
Oxygen-free radicals and other reactive molecules can required to maintain the hemoglobin level remained sta-
affect the integrity of virtually all biomolecules, including ble (see Table 2). It has been suggested that oxidative
stress could be one resistance factor to erythropoietinlipids, proteins, and nucleic acids, ultimately leading to
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response during HD and that vitamin E supplementation mulation of carbonyl intermediates resulting from oxida-
tion of glucose and ascorbic acid [39]. AGE-modifiedcould have a sparing effect on erythropoietin dose re-
quirements [20]. The use of vitamin E-modified dialysis proteins have been identified in atherosclerotic lesions
of the human aorta [40]. Therefore, the accumulation offilters demonstrated that such filters could improve
erythrocyte stability and therefore HD-related anemia AGE may be one factor that is responsible for cardiovas-
cular complications in maintenance dialysis patients. In[21]. The effects of CL-EE on chronic hemolysis in HD
patients could not be confirmed in our study as we used the present study, the use of CL-EE membranes de-
creased serum AGE levels in both the NDM and DMCL-PS, a polysulfone membrane with a fine biocompati-
bility [22], as a control. Polysulfone membranes are groups (see Fig. 2). Together with the fall in MDA action,
CL-EE may suppress the progression of HD related ath-known to be good biocompatible dialyzer membranes.
Previous studies reported that the polysulfone dialyzer erosclerosis.
b2-Microglobulin is a major protein constituent of theincreased the albumin level and decreased the activation
of leukocytes, platelets, and monocytes [23–25]. Further- amyloid fibrosis in HD-related amyloidosis, a common
complication among long-term HD patients [41]. Themore, HD using a high-flux polysulfone dialyzer was
associated with a low pentosidine plasma level, a surro- serum b2m level significantly and progressively increased
with the CL-EE membrane because of a lower reductiongate marker for carbonyl precursors [26]. However, it
has been reported that in vitro, vitamin E-modified mem- rate compared with the polysulfone membrane (see Ta-
ble 3). The differences in filtration of b2m between bothbranes induce less oxidative stress in polymorphonuclear
cells compared with polysulfone [27]. Even though a membranes are that the polysulfone dialyzer is a high-
flux membrane with a large pore size, while the backbonecrossover method was applied, time or other effects
could not be completely ruled out in our study. Neverthe- of the CL-EE dialyzer is a low-flux cellulose membrane.
Therefore, the serum b2m level became increased by theless, our results also suggest that in vivo, CL-EE, vitamin
E-coated membranes have better biocompatibility with use of the CL-EE membrane. However, it is well known
that there is no statistical correlation between its serumregard to antioxidative effects than the CL-PS polysulfone
membranes. concentration and the occurrence of the HD-related am-
yloidosis [42], and the accumulation of AGE in amyloidLipid peroxidation products such as MDA have been
identified in atherosclerotic lesions [28, 29]. Oxidatively tissue is thought to be the cause of HD-related amy-
loidosis [43]. The AGE-modified proteins have beenmodified lipoprotein is recognized by scavenger recep-
tors and taken up by macrophages, inducing the develop- shown to stimulate monocyte/macrophage to secrete
bone-resorbing cytokines so that the modification ofment of foam cells in vascular atheroma [30]. Several
groups have described the presence of elevated levels of bone matrices with AGE might play a pathophysiologi-
cal role in HD-related amyloidosis [44]. The use of CL-lipid peroxidation products in HD patients [31–34]; this
is consistent with the finding that patients on long-term EE membranes significantly decreased serum AGE lev-
els so that there is some possibility of reducing the AGE-dialysis develop atherosclerosis sooner than age-matched
controls [35, 36]. In the present study, we have demon- b2m level. Further long-term studies are needed to clarify
this issue.strated that serum MDA levels significantly decreased
after a single HD session with CL-EE compared with It has been suggested that aggregation of DNA dam-
age is relevant to the aging process and the incidence ofpredialysis (see Table 3) and that patients of the DM
group exhibited a significant reduction in MDA concen- cancer [45]. Oxidative stress is known to increase the
conversion of deoxyguanosine to 8-OHdG in DNA, andtration during six months of observation (see Fig. 1).
Because of its direct protective effect against lipid perox- therefore, 8-OHdG levels are thought to be a marker
of oxidative DNA damage [46]. Increased excretion ofidation, vitamin E appears to be an appropriate agent
to reduce HD-induced oxidative stress [18]. The long- urinary 8-OHdG is observed in patients with non–insulin-
dependent diabetes mellitus [47], atopic dermatitis [48],term use of CL-EE might therefore reduce the risk of
dialysis-related atherosclerosis. and lung cancer [49]. Previous studies have demonstrated
that 8-OHdG decreased in a time-dependent mannerThe concentration of AGE-modified proteins increases
during the aging process, as well as in diabetes and ure- after supplementation with vitamin E [50]. Our study
demonstrates, to our knowledge for the first time, thatmia, resulting in tissue damage through alterations of
their structure and function [37]. AGEs in DM patients the use of CL-EE prevented the production of 8-OHdG
during a single HD (see Table 3) and that the level ofhave been reported at a higher level than in NDM pa-
tients [38]. The present study also found that HD patients 8-OHdG was gradually decreased by the long-term use
of CL-EE, particularly in DM patients (see Fig. 3). Wewith DM exhibited higher serum AGE levels than NDM
patients (see Fig. 2), suggesting that DM patients receiv- infer from these results that oxidative damage to DNA
was diminished.ing HD were exposed to higher oxidative stress. AGE
generation in patients with uremia is stimulated by accu- The CL-EE membrane can specifically interact with
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